Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Shanghai Zheye Biotechnology divulges G12C mutant GTPase KRAS inhibitors

Sep. 29, 2021

New PDE4 inhibitors divulged by Suzhou Longbiotech Pharmaceuticals

Sep. 28, 2021

Hanyang University discovers MAPK10 inhibitors

Sep. 28, 2021

New HDAC6 inhibitors identified at Chong Kun Dang Pharmaceutical

Sep. 28, 2021

U.S. Department of Health & Human Services patents T-cell receptors against mutated RAS

Sep. 28, 2021

NLRP3 inflammasome inhibitors patented by Cadila Healthcare

Sep. 27, 2021

Servier discovers nuclear factor erythroid 2-related factor 2 activators

Sep. 27, 2021

Kallyope presents new free fatty acid FFA1 receptor agonists

Sep. 27, 2021

Japan Tobacco describes new PDHK2 inhibitors

Sep. 27, 2021

BeiGene discovers non-receptor tyrosine-protein kinase TYK2 inhibitors

Sep. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.